13.64
price up icon9.65%   1.20
after-market After Hours: 13.80 0.16 +1.17%
loading
10 X Genomics Inc stock is traded at $13.64, with a volume of 2.61M. It is up +9.65% in the last 24 hours and up +16.68% over the past month. 10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
See More
Previous Close:
$12.44
Open:
$12.56
24h Volume:
2.61M
Relative Volume:
0.96
Market Cap:
$1.56B
Revenue:
$631.73M
Net Income/Loss:
$-239.78M
P/E Ratio:
-6.7525
EPS:
-2.02
Net Cash Flow:
$-33.45M
1W Performance:
-0.94%
1M Performance:
+16.68%
6M Performance:
+64.93%
1Y Performance:
-14.91%
1-Day Range:
Value
$12.44
$13.85
1-Week Range:
Value
$12.34
$13.86
52-Week Range:
Value
$6.78
$18.21

10 X Genomics Inc Stock (TXG) Company Profile

Name
Name
10 X Genomics Inc
Name
Phone
(925) 401-7300
Name
Address
6230 STONERIDGE MALL ROAD, PLEASANTON, CA
Name
Employee
1,306
Name
Twitter
@10xgenomics
Name
Next Earnings Date
2024-10-31
Name
Latest SEC Filings
Name
TXG's Discussions on Twitter

Compare TXG with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Health Information Services icon
TXG
10 X Genomics Inc
13.64 1.55B 631.73M -239.78M -33.45M -2.02
Health Information Services icon
VEEV
Veeva Systems Inc
291.20 46.72B 2.97B 809.93M 1.33B 4.8743
Health Information Services icon
TEM
Tempus Ai Inc
89.85 14.99B 803.32M -709.10M -212.68M -7.8003
Health Information Services icon
DOCS
Doximity Inc
66.00 12.33B 550.17M 201.35M 232.07M 1.00
Health Information Services icon
HQY
Healthequity Inc
94.58 8.01B 1.15B 96.70M -161.99M 1.09
Health Information Services icon
WAY
Waystar Holding Corp
35.85 7.09B 906.14M -52.62M 89.62M -0.3621

10 X Genomics Inc Stock (TXG) Upgrades & Downgrades

Date Action Analyst Rating Change
Sep-11-25 Initiated Piper Sandler Neutral
Feb-13-25 Downgrade Leerink Partners Outperform → Market Perform
Sep-03-24 Initiated Leerink Partners Outperform
Jul-22-24 Upgrade Jefferies Hold → Buy
Jul-18-24 Downgrade JP Morgan Overweight → Neutral
Jul-10-24 Downgrade Deutsche Bank Buy → Hold
Jun-27-24 Downgrade Wolfe Research Outperform → Peer Perform
Jun-25-24 Downgrade Guggenheim Buy → Neutral
Jun-03-24 Resumed Jefferies Hold
May-01-24 Downgrade TD Cowen Buy → Hold
Dec-14-23 Initiated Guggenheim Buy
Dec-13-23 Initiated Wolfe Research Outperform
Dec-12-23 Upgrade BofA Securities Underperform → Neutral
Jul-05-23 Resumed JP Morgan Overweight
May-10-23 Initiated Barclays Overweight
Mar-31-23 Initiated Stephens Overweight
Feb-02-23 Initiated UBS Neutral
Dec-14-22 Initiated Deutsche Bank Buy
Aug-18-22 Downgrade Goldman Neutral → Sell
Jul-25-22 Initiated Canaccord Genuity Buy
Jul-15-22 Downgrade BofA Securities Neutral → Underperform
Jul-15-22 Downgrade William Blair Outperform → Mkt Perform
Oct-15-21 Resumed Cowen Outperform
Sep-14-21 Downgrade BofA Securities Buy → Neutral
Mar-15-21 Initiated William Blair Outperform
Dec-02-20 Initiated Goldman Neutral
Sep-09-20 Initiated Morgan Stanley Overweight
Jul-10-20 Initiated Stifel Buy
Mar-05-20 Initiated Guggenheim Buy
Jan-07-20 Initiated Citigroup Buy
Oct-07-19 Initiated BofA/Merrill Buy
Oct-07-19 Initiated Cowen Outperform
Oct-07-19 Initiated JP Morgan Overweight
Sep-24-19 Initiated Evercore ISI Outperform
View All

10 X Genomics Inc Stock (TXG) Latest News

pulisher
03:33 AM

Ethic Inc. Invests $289,000 in 10x Genomics $TXG - MarketBeat

03:33 AM
pulisher
Oct 30, 2025

Is 10x Genomics Inc. stock a safe investment in uncertain marketsExit Point & Verified Short-Term Trading Plans - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

10x Genomics Launches the Next Generation of Chromium Flex to Empower Scientists to Massively Scale Single Cell Research - Lelezard

Oct 30, 2025
pulisher
Oct 29, 2025

ARK Investment Acquires New Shares in 10x Genomics (TXG) - GuruFocus

Oct 29, 2025
pulisher
Oct 29, 2025

10x Genomics Launches New Chromium Flex for Single-Cell Research - Contract Pharma

Oct 29, 2025
pulisher
Oct 29, 2025

10x Genomics (NASDAQ: TXG) launches Chromium Flex enabling 384-sample plate multiplexing - Stock Titan

Oct 29, 2025
pulisher
Oct 28, 2025

Why 10x Genomics Inc. stock appeals to dividend seekers2025 Historical Comparison & AI Forecast Swing Trade Picks - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 28, 2025

Is 10x Genomics Inc. (1KJ) stock undervalued historicallyEarnings Risk Summary & Short-Term Trading Alerts - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

IQ EQ FUND MANAGEMENT IRELAND Ltd Purchases 184,757 Shares of 10x Genomics $TXG - MarketBeat

Oct 28, 2025
pulisher
Oct 28, 2025

Is 10x Genomics Inc. stock ready for a breakoutNew Guidance & Smart Allocation Stock Reports - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

How geopolitical tensions affect 10x Genomics Inc. stockDividend Hike & Risk Controlled Daily Trade Plans - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Advanced analytics toolkit walkthrough for 10x Genomics Inc.Insider Buying & Weekly Watchlist for Consistent Profits - newser.com

Oct 28, 2025
pulisher
Oct 27, 2025

What’s the recovery path for long term holders of 10x Genomics Inc.2025 Risk Factors & AI Based Trade Execution Alerts - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Is 10x Genomics Inc. stock dividend yield sustainable2025 Risk Factors & AI Powered Market Entry Strategies - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

How 10x Genomics Inc. stock trades before earningsCPI Data & Expert Curated Trade Setups - Fundação Cultural do Pará

Oct 27, 2025
pulisher
Oct 27, 2025

Sumitomo Mitsui Trust Group Inc. Acquires 654,597 Shares of 10x Genomics $TXG - MarketBeat

Oct 27, 2025
pulisher
Oct 26, 2025

Ranking 10x Genomics Inc. among high performing stocks via toolsStop Loss & Fast Momentum Entry Tips - newser.com

Oct 26, 2025
pulisher
Oct 26, 2025

Is 10x Genomics Inc. stock entering bullish territoryJuly 2025 Snapshot & Entry and Exit Point Strategies - newser.com

Oct 26, 2025
pulisher
Oct 26, 2025

Is 10x Genomics Inc. (1KJ) stock nearing a technical breakoutWeekly Investment Recap & Smart Swing Trading Alerts - newser.com

Oct 26, 2025
pulisher
Oct 25, 2025

Will 10x Genomics’ (TXG) AI Partnership Shift Its Long-Term Competitive Edge in Genomics? - Yahoo Finance

Oct 25, 2025
pulisher
Oct 24, 2025

What momentum shifts mean for 10x Genomics Inc.July 2025 Macro Moves & Free Reliable Trade Execution Plans - newser.com

Oct 24, 2025
pulisher
Oct 24, 2025

Lancaster Opens $7 Million Position in 10x Genomics (TXG) - The Globe and Mail

Oct 24, 2025
pulisher
Oct 24, 2025

Lancaster Opens $7 Million Position in 10x Genomics (TXG) - The Motley Fool

Oct 24, 2025
pulisher
Oct 24, 2025

Cookson Peirce & Co. Inc. Takes Position in 10x Genomics $TXG - MarketBeat

Oct 24, 2025
pulisher
Oct 23, 2025

SPT Labtech and 10x Genomics Partner To Automate Single Cell Workflows - Technology Networks

Oct 23, 2025
pulisher
Oct 23, 2025

10x Genomics and Prognosys Biosciences Allege Illumina Infringed Four Spatial Transcriptomics Patents - IPWatchdog.com

Oct 23, 2025
pulisher
Oct 21, 2025

Why 10x Genomics Inc. (1KJ) stock trades below fair valueQuarterly Market Summary & Verified Chart Pattern Signals - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Will 10x Genomics Inc. stock gain from lower inflationEarnings Miss & Fast Gain Stock Trading Tips - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

10x Genomics Hits Illumina With 2 Gene Tech Patent Suits - Law360

Oct 21, 2025
pulisher
Oct 21, 2025

10x sues rival Illumina over gene-sequencing patents - Reuters

Oct 21, 2025
pulisher
Oct 21, 2025

10x Genomics (TXG) Takes Legal Action Against Illumina Over Pate - GuruFocus

Oct 21, 2025
pulisher
Oct 21, 2025

Illumina faces patent lawsuits from 10x Genomics over gene sequencing tech - Seeking Alpha

Oct 21, 2025
pulisher
Oct 21, 2025

Illumina Hit with 10X Genomics Patent Suits Over Sequencing Tech - Bloomberg Law News

Oct 21, 2025
pulisher
Oct 21, 2025

10x Genomics, Inc. (TXG) Stock Analysis: A 13.07% Potential Upside In Health Information Services - DirectorsTalk Interviews

Oct 21, 2025
pulisher
Oct 21, 2025

10x Genomics (TXG) Moves 11.1% Higher: Will This Strength Last? - Yahoo Finance

Oct 21, 2025
pulisher
Oct 20, 2025

10x Genomics partners with Anthropic to make biology research more accessible - Investing.com Canada

Oct 20, 2025
pulisher
Oct 20, 2025

10X Genomics (TXG) Partners with Anthropic to Simplify Scientifi - GuruFocus

Oct 20, 2025
pulisher
Oct 20, 2025

Can 10x Genomics Inc. stock deliver surprise earnings beatWeekly Trade Review & Daily Oversold Stock Bounce Ideas - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

10X Genomics to integrate analysis tools into Anthropic's Claude for Life Sciences - Seeking Alpha

Oct 20, 2025
pulisher
Oct 20, 2025

10x Genomics partners with Anthropic to make biology research more accessible By Investing.com - Investing.com South Africa

Oct 20, 2025
pulisher
Oct 20, 2025

10x Genomics Partners With Anthropic To Bring AI Tools For Researchers - Stocktwits

Oct 20, 2025
pulisher
Oct 20, 2025

10x Genomics & Anthropic partner to make single cell & spatial analysis more accessible - MarketScreener

Oct 20, 2025
pulisher
Oct 20, 2025

10x Genomics, Inc. and Anthropic Partner to Make Single Cell and Spatial Analysis More Accessible Through Claude for Life Sciences - MarketScreener

Oct 20, 2025
pulisher
Oct 20, 2025

Why Is 10x Genomics (TXG) Stock Rocketing Higher Today - Yahoo Finance

Oct 20, 2025
pulisher
Oct 20, 2025

Zacks.com featured highlights include Red Robin Gourmet Burgers, 10x Genomics, Norwegian Cruise Line, Electromed and Analog Devices - Yahoo Finance

Oct 20, 2025

10 X Genomics Inc Stock (TXG) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

10 X Genomics Inc Stock (TXG) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Taich Adam
Chief Financial Officer
Aug 22 '25
Sale
13.79
22,315
307,657
309,273
Hindson Benjamin J.
See Remarks
Aug 22 '25
Sale
13.79
7,486
103,209
440,888
$11.63
price up icon 2.38%
$28.12
price down icon 0.07%
$24.30
price down icon 0.86%
$37.16
price up icon 1.61%
$33.05
price up icon 0.79%
health_information_services WAY
$35.85
price down icon 3.26%
Cap:     |  Volume (24h):